4
Changes in Ownership
Theriva Biologics, Inc. Filed Acc 0001104659-23-018901
CEO and CFO bought 25,000 shares at $1.04 ($26,075)
From the SEC's structured data for this filing
Trades in this filing
SHALLCROSS STEVEN A · CEO and CFO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-02-10 | Purchase : show line 1 in the form | +25,000 | $1.04 | $26,075 | 210,000 | D |
| Open-market purchases · 25,000 sh · avg $1.04 · $26,075 | ||||||
Loading xslF345X03/tm236426-1_4.xml…